Stocks in Focus

“Set to Benefit Most if the ‘Ban on Korean Content’ Is Lifted”… Entertainment and Media Stocks Hit Daily Price Limits One After Another [Featured Stocks]

Kim Kyung-eun
2026-11-19 10:37:31
[Edaily Reporter Kim Kyung-eun ] Entertainment and media stocks are surging across the board amid expectations that China will ease its “ban on Korean content” (Hanhanryeong). Analysts in the securities industry predict that the entertainment sector will benefit the most from the lifting of the ban.

President Lee Jae-myung and Chinese President Xi Jinping shake hands during the signing ceremony for the South Korea-China MOU held at the Great Hall of the People in Beijing on the 5th. (Photo = Yonhap News)


According to MP Doctor on the 19th, as of 10:23 a.m. that day, ASTORY Co., Ltd.(241840)was trading at 2,730 won—up 30.00% from the previous trading day—hitting the daily price limit. Mr. Blue Corporation(207760)(29.99%) and Studio Dragon Corporation(253450)(29.96%) also soared to their daily price limits.

In addition, entertainment and media-related stocks such as CJ ENM CO., Ltd.(035760)(22.89%), YG PLUS(037270)(14.47%), PAN ENTERTAINMENT CO., LTD.(068050)(11.09%), CHOROKBAEM MEDIA CO.,LTD.(047820)(14.12%), and YLAB Corporation(432430)(10.59%) also rose sharply.

Among gaming stocks, #SamAge hit the daily price limit, trading at 1,355 won—up 29.91% from the previous trading day. Wemade Max(101730)is also trading at 3,932 won, up 20.61%.

At the South Korea-China summit the previous day, the two countries announced a substantive agreement on follow-up negotiations for the Free Trade Agreement (FTA) on services and investment. China agreed to grant most-favored-nation treatment to South Korean films and games and to apply the principle of non-discrimination in the pre-screening process. The scope of co-productions, which had been limited to films, was expanded to include dramas, animation, variety shows, and documentaries.

The securities industry forecasts that the entertainment sector will benefit the most from the easing of the “ban on Korean content.” This is because, even during the ban, while Korean singers were able to sell albums and hold small-scale fan meetings in China, large-scale concerts were effectively blocked. As for media production companies, the outlook is that they can increase revenue simply by selling existing dramas to China.

Choi Min-ha, an analyst at SamsungSecurities, predicted, “Since a compromise has been reached to gradually lift restrictions starting with acceptable sectors, the agreement on the annex regarding the co-production of dramas and variety shows could serve as a trigger to open new avenues for media production companies that have suffered from prolonged sluggish earnings and stock prices. For entertainment companies, it could fuel expectations of earnings upside stemming from the resumption of on-site performances and offline activities in China.”

While the gaming sector is viewed positively given that the institutional foundation for entering the Chinese market has been established, the short-term impact on earnings is expected to be limited.

Ko Jun-hyuk, an analyst at Shinhan Investment Securities, analyzed, “Most-Favored-Nation treatment and the principle of non-discrimination in pre-screening do not immediately imply changes to the game license review process or a shortening of review periods.” He added, “Since mobile games have already been securing Chinese demand through foreign investment game licenses and PC games through the global Steam platform, the re-rating of the gaming sector as a whole will be limited based on this agreement alone.”

Economy

Corporation

IT·Science

Economy

Genexine, Inc.: How Long Can It Keep Selling Assets to Stay Afloat?…Debt Alone Totals 105.4 Billion Won

Genexine, Inc.(095700)is securing the cash needed for research and development and operations by disposing of its financial assets, but its debt and interest burden remain significant. Genexine, In…
2026-11-19 10:32:02

Corporation

After Enhancing the Flavor and Adding Protein… TakeFit Sees Sales Jump 48%

NamyangDairyProducts(003920)’s protein brand “TakeFit” saw its cumulative sales for the third quarter of this year increase by 48.3% compared to the same period last year. Analysts attribute this grow…
2026-11-19 09:14:40

IT·Science

Park Beom-chan, CEO of Y-Bio: “Big Pharma’s Interest in SITC Results on the Rise… Aiming to Export AR170 Technology Next Year”

“Through a study on patient-derived tissue recently presented at the Society for Immunotherapy of Cancer (SITC) in the U.S., we have confirmed the potential for our next-generation immuno-oncology dru…
2026-11-19 11:01:02